The Hong Kong diastolic heart failure study: A randomised controlled trial of diuretics, irbesartan and ramipril on quality of life, exercise capacity, left ventricular global and regional function in heart failure with a normal ejection fraction

Heart

Volumn 94, Issue 5, 2008, Pages 573-580

  Yip, G W K ^a   Wang, M ^a   Wang, T ^a   Chan, S ^a   Fung, J W H ^a   Yeung, L ^a   Yip, T ^b   Lau, S T ^c   Lau, C P ^d   Tang, M O ^d   Yu, C M ^a   Sanderson, John ^a,e  

^a CHINESE UNIVERSITY OF HONG KONG   (Hong Kong)

^b YAN CHAI HOSPITAL   (Hong Kong)

^c PRINCESS MARGARET HOSPITAL   (Hong Kong)

^d UNIVERSITY OF HONG KONG   (Hong Kong)

^e UNIVERSITY OF BIRMINGHAM   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

AMINO TERMINAL PRO BRAIN NATRIURETIC PEPTIDE; DIURETIC AGENT; FUROSEMIDE; HYDROCHLOROTHIAZIDE; HYDROCHLOROTHIAZIDE PLUS TRIAMTERENE; INDAPAMIDE; IRBESARTAN; METHYLDOPA; RAMIPRIL; THIAZIDE DIURETIC AGENT;

ADULT; AGED; ARTICLE; CLINICAL TRIAL; COMBINATION CHEMOTHERAPY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIASTOLIC BLOOD PRESSURE; DIASTOLIC HEART FAILURE; DOPPLER ECHOCARDIOGRAPHY; DRUG DOSE TITRATION; EXERCISE; FEMALE; HEART EJECTION FRACTION; HEART LEFT VENTRICLE FUNCTION; HONG KONG; HOSPITALIZATION; HUMAN; MAJOR CLINICAL STUDY; MALE; MONOTHERAPY; MULTICENTER STUDY; PRIORITY JOURNAL; QUALITY OF LIFE; RANDOMIZED CONTROLLED TRIAL; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; SCORING SYSTEM; SINGLE BLIND PROCEDURE; SYSTOLIC BLOOD PRESSURE; TREATMENT OUTCOME;

AGED; ANTIHYPERTENSIVE AGENTS; BIPHENYL COMPOUNDS; DIURETICS; DRUG THERAPY, COMBINATION; ECHOCARDIOGRAPHY; EPIDEMIOLOGIC METHODS; EXERCISE TOLERANCE; FEMALE; HEART FAILURE, DIASTOLIC; HONG KONG; HUMANS; MALE; QUALITY OF LIFE; RAMIPRIL; TETRAZOLES; TREATMENT OUTCOME; VENTRICULAR DYSFUNCTION, LEFT;

EID: 42549149364     PISSN: 13556037     EISSN: None     Source Type: Journal    
DOI: 10.1136/hrt.2007.117978     Document Type: Article

References (40)

1. Hogg K, Swedberg K, McMurray J. Heart failure with preserved left ventricular systolic function: epidemiology, clinical characteristics, and prognosis. J Am Coll Cardiol 2004;43:317-27.
2. Sanderson JE. Review: Heart Failure with normal ejection fraction. Heart 2007;93:155-8.
3. Yusuf S, Pfeffer MA, Swedberg K, et al. for the CHARM Investigators and Committees. Effect of candesartan in patients with chronic heart failure and preserved left-ventricular ejection fraction: the CHARM-Preserved Trial. Lancet 2003;363:777-81.
4. Cleland JG, Tendera M, Adamus J, et al. PEP-CHF investigators. The Perindopril in elderly people with chronic heart failure (PEP-CHF) study. Eur Heart J 2006;27:2338-45.
5. Yip G, Wang M, Zhang Y, et al. Left ventricular long axis function in diastolic heart failure is reduced in both diastole and systole: time for a redefinition? Heart 2002;87:121-5.
6. Petrie MC, Caruana L, Berry C, et al. "Diastolic heart failure" or heart failure caused by subtle left ventricular systolic dysfunction? Heart 2002;87:29-31.
7. Yu CM, Lin H, Yang H, et al. Progression of systolic abnormalities in patients with "isolated" diastolic heart failure and diastolic dysfunction. Circulation 2002;105:1195-201.
8. Nikitin NP, Witte KK, Clark AL, et al. Color tissue Doppler-derived long-axis left ventricular function in heart failure with preserved global systolic function. Am J Cardiol 2002;90:1174-7.
9. Bruch C, Gradaus R, Gunia S, et al. Doppler tissue analysis of mitral annular velocities: evidence for systolic abnormalities in patients with diastolic heart failure. J Am Soc Echocardiogr 2003;16:1031- 6.
10. Vinereanu D, Nicolaides E, Tweddel AC, et al. "Pure" diastolic dysfunction is associated with long-axis systolic dysfunction. Implications for the diagnosis and classification of heart failure. Eur J Heart Fail 2005;7:820-8.
11. Garcia EH, Perna ER, Farias EF, et al. Reduced systolic performance by tissue Doppler in patients with preserved and abnormal ejection fraction: new insights in chronic heart failure. Int J Cardiol 2006;108:181-8.
12. Wang M, Yip GW, Wang AY, et al. Tissue Doppler imaging provides incremental prognostic value in patients with systemic hypertension and left ventricular hypertrophy. J Hypertens 2005;23:183-91.
13. Vinereanu O, Nicolaides E, Tweddel AC, et al. Subclinical left ventricular dysfunction in asymptomatic patients with Type II diabetes mellitus, related to serum lipids and glycated haemoglobin. Clin Sci (Lond) 2003;105:591-9.
14. Carlsson M, Ugander M, Mosen H, et al. Atrioventricular plane displacement is the major contributor to left ventricular pumping in healthy adults, athletes, and patients with dilated cardiomyopathy. Am J Physiol Heart Circ Physiol 2007;292:H1452-9.
15. Rector TS, Kubo SH, Cohn JN. Patients' self-assessment of their congestive heart failure: content, reliability, and validity of a new measure, the Minnesota Living with Heart Failure Questionnaire. Heart Failure 1987;3:198-209.
16. Sanderson JE, Chan SKW, Yip G, et al. Beta-blockade in heart failure: a comparison of carvedilol with metoprolol. J Am Coll Cardiol 1999;34:1522-8.
17. Yusuf S, Ysuyuki R. Using exercise endpoints in heart failure trials: design considerations. Eur Heart J 1996;17:4-6.
18. Wang M, Yip GWK, Wang AYM, et al. Peak early diastolic mitral annulus velocity by tissue Doppler imaging adds independent and incremental prognostic value. J Am Coll Cardiol 2003;41:820-6.
19. Devereux RB, Alonso DR, Lutas EM, et al. Echocardiographic assessment of left ventricular hypertrophy: comparison to necropsy findings. Am J Cardiol 1986;57:450-8.
20. Nagueh SF, Middleton KJ, Kopelen HA, et al. Doppler tissue imaging: a noninvasive technique for evaluation of left ventricular relaxation and estimation of filling pressures. J Am Coll Cardiol 1997;30:1527-33.
21. Bennett SJ, Oldridge NB, Eckert GJ, et al. Comparison of quality of life measures in heart failure. Nurs Res 2003;52:207- 16.
22. Maurer MS, Spevack D, Burkhoff D, et al. Diastolic dysfunction: can it be diagnosed by Doppler echocardiography? J Am Coll Cardiol 2004;44:1543-9.
23. Maurer MS, Kronzon I, Burkhoff D. Ventricular pump function in heart failure with normal ejection fraction: insights from pressure-volume measurements. Prog Cardiovasc Dis 2006;49:182-95.
24. Olsson LG, Swedberg K, Clark AL, et al. Six minute corridor walk test as an outcome measure for the assessment of treatment in randomized, blinded intervention trials of chronic heart failure: a systematic review. Eur Heart J 2005;26:749-50.
25. Wang M, Yip GWK, Yu CM, et al. Independent and incremental prognostic value of early diastolic annular velocity in patients with impaired left ventricular systolic function. J Am Coll Cardiol 2005;45:272-7.
26. Vinereanu D, Lim PO, Frenneaux MP, et al. Reduced myocardial velocities of left ventricular long-axis contraction identify both systolic and diastolic heart failure-a comparison with brain natriuretic peptide. Eur J Heart Fail 2005;7:512-9.
27. Hasegawa H, Little WC, Ohno M, et al. Diastolic mitral annular velocity during the development of heart failure. J Am Coll Cardiol 2003;41:1590-7.
28. Gibson DG, Francis DP. Clinical assessment of left ventricular diastolic function. Heart 2003;89:231-8.
29. Little WC. Enhanced load dependence of relaxation in heart failure. Circulation 1992;85:2326-8.
30. Mottram PM, Haluska BA, Leano R, et al. Relation of arterial stiffness to diastolic dysfunction in hypertensive heart disease. Heart 2005;91:1551-6.
31. Devereux RB, Dahlof B, Gerdts E, et al. Regression of hypertensive left ventricular hypertrophy by losartan compared with atenolol: the Losartan Intervention for Endpoint Reduction in Hypertension (LIFE) trial. Circulation 2004;110:1456-62.
32. Neaton JD, Grimm Jr RH, Prineas RJ, et al. Treatment of Mild Hypertension Study: final results. JAMA 1993;270:713-24.
33. Solomon SD, Janardhanan R, Verma A, et al. Effect of angiotensin receptor blockade and antihypertensive drugs on diastolic function in patients with hypertension and diastolic dysfunction: a randomized trial. Lancet 2007;369:2079-87.
34. Weber KT, Brilla CG. Pathological hypertrophy and cardiac interstitium: fibrosis and renin-angiotensin-aldosterone system. Circulation 1991;83:1849-65.
35. Shan K, Bick RJ, Poindexter BJ, et al. Relation of tissue Doppler derived myocardial velocities to myocardial structure and beta-adrenergic receptor density in humans. J Am Coll Cardiol 2000;36:891-6.
36. Weber KT. Targeting pathological remodeling. Concepts of cardioprotection and reparation. Circulation 2000;102:1342-5.
37. Brilla CG, Funck RC, Rupp H. Lisinopril-mediated regression of myocardial fibrosis in patients with hypertensive heart disease. Circulation 2000;102:1388-93.
38. Diez J, Querejeta R, Lopez B, et al. Losartan-dependent regression of myocardial fibrosis is associated with reduction of left ventricular chamber stiffness in hypertensive patients. Circulation 2002;105:2512-7.
39. Paulus WJ, Tschope C, Sanderson JE, et al. How to diagnose diastolic heart failure: a consensus statement on the diagnosis of heart failure with normal left ventricular ejection fraction by the Heart Failure and Echocardiography Associations of the European Society of Cardiology. Eur Heart J 2007;28:2539-50.
40. Dokainish H, Zoghbi WA, Lakkis NM, et al. Optimal non-invasive assessment of left ventricular filling pressures: a comparison of tissue Doppler echocardiography and B-type natriuretic peptide in patients with pulmonary artery catheters. Circulation 2004;109:2432-9.